Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2024 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2024 Earnings Call Transcript August 7, 2024Madrigal Pharmaceuticals, Inc. beats earnings expectations.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
2. | Millennium Management Israel Englander | 0 | $0 | -100% | 0% |
3. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
4. | Baker Bros. Advisors Julian Baker And Felix Baker | 0 | $0 | -100% | 0% |
5. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$229.86 | 3,960 | Director | 1,793,403 | 2023-12-14 | Filing | |
$229.86 | 316 | Director | 185,979 | 2023-12-14 | Filing | |
$228.79 | 2,204 | Director | 1,789,443 | 2023-12-14 | Filing | |
$228.79 | 176 | Director | 185,663 | 2023-12-14 | Filing | |
$227.86 | 11,602 | Director | 1,787,239 | 2023-12-14 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$280.00 | 1,900 | 5,500 | 2024-06-14 | Filing | ||
$285.00 | 2,000 | 5,500 | 2024-06-12 | Filing | ||
$231.34 | 1,036 | 5,500 | 2024-05-21 | Filing | ||
$219.90 | 100 | 413,362 | 2024-05-14 | Filing | ||
$218.99 | 1,000 | 413,462 | 2024-05-14 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 0 | $0 | 0% | |
2. | 0 | $0 | 0% | |
3. | 0 | $0 | 0% | |
4. | 0 | $0 | 0% | |
5. | 0 | $0 | 0% |